XML 60 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value - Additional Information (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2023
USD ($)
Installment
Apr. 07, 2022
Oct. 31, 2024
USD ($)
Jul. 31, 2024
USD ($)
Installment
Apr. 30, 2024
USD ($)
Installment
Apr. 30, 2022
USD ($)
Installment
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2022
USD ($)
Installment
$ / shares
shares
Dec. 31, 2021
USD ($)
Dec. 31, 2018
USD ($)
Installment
shares
Nov. 21, 2022
shares
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Loss on debt extinguishment                 $ (6,981) $ 2,298    
Net change to contingent consideration                   1,622    
Change in fair value of warrant liability                 $ (84)      
Warrants, expires period                 Feb. 23, 2028      
IPO                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Warrant, exercise price | $ / shares                 $ 4.46      
Warrant issued to purchase shares | shares                 103,326      
2018 Notes | Series G Preferred Stock                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Warrant issued to purchase shares | shares                 613,333      
Warrant, exercise price | $ / shares                 $ 0.75      
Integrated Diagnostics, Inc                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Business acquisition contingent consideration gross margin target               $ 2,000     $ 2,000  
Business acquisition contingent consideration gross margin target period                     7 years  
Integrated Diagnostics, Inc | Common Stock                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Contingent consideration shares | shares                     2,520,108  
Contingent Consideration                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Interest expense due to passage of time and fixed payment schedule             $ 1,100   $ 3,100 $ 2,200    
Reduction in contingent consideration             1,000          
Contingent Consideration | Discount Rate                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Changes in fair value             $ 100          
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]             Interest Expense          
Contingent Consideration | Interest Expense                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Loss on debt extinguishment             $ (2,900)          
Contingent Consideration | Integrated Diagnostics, Inc                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Business acquisition description                 requires additional consideration to be paid by the Company to such shareholders upon attainment of a three-consecutive month      
Business acquisition contingent consideration gross margin target               $ 2,000     $ 2,000  
Business acquisition contingent consideration gross margin target period                     7 years  
Contingent Consideration | Integrated Diagnostics, Inc | Third Amendment to APA Agreement                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Contingent consideration number of installments | Installment           5            
Milestone payment           $ 2,000            
Percentage of interest on installment payments   10.00%                    
Contingent Consideration | Integrated Diagnostics, Inc | Third Amendment to APA Agreement | Scenario Forecast                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Contingent consideration number of installments | Installment 3     1 1              
Milestone payment $ 3,000     $ 8,400 $ 5,000              
Exit fee payment     $ 6,100                  
Contingent Consideration | Integrated Diagnostics, Inc | Common Stock                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Business acquisition description                 If Indi elected to not exercise its option, the Company had 12 months to repurchase the common stock in two equal and consecutive quarterly cash installments totaling $37.0 million.      
Contingent consideration shares | shares                     2,520,108  
Contingent consideration number of installments | Installment                 6   8  
Contingent consideration arrangements, common shares, redemption amount                 $ 4,600   $ 37,000  
Repayments of debt                 9,300      
Business combination contingent consideration final payment                 $ 37,000      
Contingent Consideration | Integrated Diagnostics, Inc | Common Stock | Repurchase                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Contingent consideration number of installments | Installment                     2  
Contingent consideration cash payment                     $ 37,000  
Contingent Consideration | Minimum                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range                 11.00%      
Contingent Consideration | Maximum                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range                 16.00%      
Warrant Liabilities                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Warrant issued to purchase shares | shares                       5,000,000
Initial fairvalue of additional warrants                 $ 100      
Change in fair value of warrant liability                 $ 100      
Warrant Liabilities | Minimum | Volatility rate | Tranche B Loan                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Warrants and Rights Outstanding, Measurement Input                 78      
Warrant Liabilities | Maximum | Volatility rate | Tranche B Loan                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Warrants and Rights Outstanding, Measurement Input                 82